Parkinson's disease managing reversible neurodegeneration [Corrigendum]
Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest...
Main Authors: | Hinz M, Stein A, Cole T, McDougall B, Westaway M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | https://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT |
Similar Items
-
Parkinson’s disease managing reversible neurodegeneration
by: Hinz M, et al.
Published: (2016-04-01) -
Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
by: Hinz M, et al.
Published: (2020-12-01) -
Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
Amino acid management of Parkinson's disease: a case study [Corrigendum]
by: Hinz M, et al.
Published: (2016-06-01) -
Parkinson's disease: carbidopa, nausea, and dyskinesia
by: Hinz M, et al.
Published: (2014-11-01)